标题
Mechanism of action of mRNA-based vaccines
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 16, Issue 9, Pages 871-881
出版商
Informa UK Limited
发表日期
2017-07-13
DOI
10.1080/14760584.2017.1355245
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
- (2017) Darin K. Edwards et al. Journal of Translational Medicine
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- The 'anti-hype' vaccine
- (2017) Laura DeFrancesco NATURE BIOTECHNOLOGY
- Type I Interferons Modulate CD8 + T Cell Immunity to mRNA Vaccines
- (2017) Ans De Beuckelaer et al. TRENDS IN MOLECULAR MEDICINE
- Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
- (2016) Abderraouf Selmi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recent innovations in mRNA vaccines
- (2016) Jeffrey B Ulmer et al. CURRENT OPINION IN IMMUNOLOGY
- Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
- (2016) Ans De Beuckelaer et al. MOLECULAR THERAPY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
- (2016) Diletta Magini et al. PLoS One
- Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, andToxoplasma gondiichallenges with a single dose
- (2016) Jasdave S. Chahal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
- (2016) Aleksandra Kowalczyk et al. VACCINE
- Alphavirus Infection: Host Cell Shut-Off and Inhibition of Antiviral Responses
- (2016) Jelke Fros et al. Viruses-Basel
- An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
- (2016) Margit Schnee et al. PLoS Neglected Tropical Diseases
- Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
- (2016) Katrijn Broos et al. Molecular Therapy-Nucleic Acids
- Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
- (2015) Hyewon Youn et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes
- (2015) Sandra Lazzaro et al. IMMUNOLOGY
- A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
- (2015) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF CANCER
- A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates
- (2015) Oleg V. Pyankov et al. JOURNAL OF INFECTIOUS DISEASES
- Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
- (2015) Michela Brazzoli et al. JOURNAL OF VIROLOGY
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Control of alphavirus-based gene expression using engineered riboswitches
- (2015) Christie L. Bell et al. VIROLOGY
- The 5′ and 3′ ends of alphavirus RNAs – Non-coding is not non-functional
- (2015) Jennifer L. Hyde et al. VIRUS RESEARCH
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy
- (2015) Susanne M. Rittig et al. OncoImmunology
- Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
- (2015) Hubert Kübler et al. Journal for ImmunoTherapy of Cancer
- Intralymphatic immunotherapy
- (2015) Gabriela Senti et al. World Allergy Organization Journal
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
- (2014) Martin Sebastian et al. BMC CANCER
- The ReNAissanCe of mRNA-based cancer therapy
- (2014) Sandra Van Lint et al. Expert Review of Vaccines
- Self-replicating alphavirus RNA vaccines
- (2014) Karl Ljungberg et al. Expert Review of Vaccines
- Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
- (2014) W. M. Bogers et al. JOURNAL OF INFECTIOUS DISEASES
- Kinetic and Phenotypic Analysis of CD8+ T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations
- (2014) M. L. Knudsen et al. JOURNAL OF VIROLOGY
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- A Viral RNA Structural Element Alters Host Recognition of Nonself RNA
- (2014) J. L. Hyde et al. SCIENCE
- Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice
- (2014) Yingxia Wen et al. VACCINE
- Alphavirus-Based Vaccines
- (2014) Kenneth Lundstrom Viruses-Basel
- Regulation and dysregulation of 3′UTR-mediated translational control
- (2013) Jie Jia et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Potential therapeutic applications of RNA cap analogs
- (2013) Marcin Ziemniak et al. Future Medicinal Chemistry
- Staufen1 senses overall transcript secondary structure to regulate translation
- (2013) Emiliano P Ricci et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Challenges and advances towards the rational design of mRNA vaccines
- (2013) Charlotte Pollard et al. TRENDS IN MOLECULAR MEDICINE
- Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity
- (2013) Giulietta Maruggi et al. VIROLOGY
- mRNA
- (2013) Sandra Van Lint et al. Human Vaccines & Immunotherapeutics
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Cationic lipids activate intracellular signaling pathways
- (2012) Caroline Lonez et al. ADVANCED DRUG DELIVERY REVIEWS
- Engineering Nano- and Microparticles to Tune Immunity
- (2012) James J. Moon et al. ADVANCED MATERIALS
- TLR signaling in B-cell development and activation
- (2012) Zhaolin Hua et al. Cellular & Molecular Immunology
- Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
- (2012) Mariola Fotin-Mleczek et al. JOURNAL OF GENE MEDICINE
- Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
- (2012) Rosemary L Kanasty et al. MOLECULAR THERAPY
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
- (2011) Carlo Iavarone et al. JOURNAL OF IMMUNOLOGY
- ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells
- (2011) P. Duewell et al. JOURNAL OF IMMUNOLOGY
- In Vitroandin VivomRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
- (2011) Xingfang Su et al. MOLECULAR PHARMACEUTICS
- Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
- (2011) Christina Lorenz et al. RNA Biology
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
- (2010) A N Kuhn et al. GENE THERAPY
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
- (2010) Francesca Avogadri et al. PLoS One
- Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein
- (2010) Catherine C. Cruz et al. VIROLOGY
- Toll-like receptors - sentries in the B-cell response
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy
- (2009) Julia M. Martínez-Gómez et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Venezuelan Equine Encephalitis Virus Disrupts STAT1 Signaling by Distinct Mechanisms Independent of Host Shutoff
- (2009) J. D. Simmons et al. JOURNAL OF VIROLOGY
- Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy
- (2009) Sergey S Seregin et al. MOLECULAR THERAPY
- Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells
- (2009) Sammy Bedoui et al. NATURE IMMUNOLOGY
- Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
- (2009) David I. Bernstein et al. VACCINE
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
- (2008) G. Senti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started